{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T18:36:54Z","timestamp":1767206214724,"version":"build-2238731810"},"update-to":[{"DOI":"10.3390\/cancers13112780","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T00:00:00Z","timestamp":1715731200000},"record-id":"53721"},{"DOI":"10.3390\/cancers13112780","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T00:00:00Z","timestamp":1622678400000}}],"reference-count":1,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T00:00:00Z","timestamp":1715731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.mdpi.com"],"crossmark-restriction":true},"short-container-title":["Cancers"],"abstract":"<jats:p>The journal retracts the article, \u201cAnti-Cancer Activities of Thyrointegrin \u03b1v\u03b23 Antagonist Mono- and Bis-Triazole Tetraiodothyroacetic Acid Conjugated via Polyethylene Glycols in Glioblastoma\u201d [...]<\/jats:p>","DOI":"10.3390\/cancers16101880","type":"journal-article","created":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T06:14:42Z","timestamp":1715753682000},"page":"1880","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["RETRACTED: Godugu et al. Anti-Cancer Activities of Thyrointegrin \u03b1v\u03b23 Antagonist Mono- and Bis-Triazole Tetraiodothyroacetic Acid Conjugated via Polyethylene Glycols in Glioblastoma. Cancers 2021, 13, 2780"],"prefix":"10.3390","volume":"16","author":[{"given":"Kavitha","family":"Godugu","sequence":"first","affiliation":[{"name":"The Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY 12208, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1829-3086","authenticated-orcid":false,"given":"Mehdi","family":"Rajabi","sequence":"additional","affiliation":[{"name":"The Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY 12208, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9294-015X","authenticated-orcid":false,"given":"Shaker A.","family":"Mousa","sequence":"additional","affiliation":[{"name":"The Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY 12208, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,5,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Godugu, K., Rajabi, M., and Mousa, S.A. (2021). RETRACTED: Anti-Cancer Activities of Thyrointegrin \u03b1v\u03b23 Antagonist Mono- and Bis-Triazole Tetraiodothyroacetic Acid Conjugated via Polyethylene Glycols in Glioblastoma. Cancers, 13, corrected in Cancers 2022, 14, 5371. https:\/\/doi.org\/10.3390\/cancers14215371.","DOI":"10.3390\/cancers14215371"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/10\/1880\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T07:00:28Z","timestamp":1715756428000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/10\/1880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,15]]},"references-count":1,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["cancers16101880"],"URL":"https:\/\/doi.org\/10.3390\/cancers16101880","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,15]]}}}